(Bloomberg) -- Yields on benchmark 10-year Treasury notes rose to the highest in two months as minutes from the most recent Federal Reserve meeting suggested policy makers are more concerned about inflation than slowing economic growth.
Yields rose yesterday when a private report showed consumers' expectations for inflation a year from now increased. Four Fed officials this week suggested higher interest rates may be needed to keep price gains from accelerating.
Read more at Bloomberg Bonds News
Saturday, April 14, 2007
Stocks buoyed by profit outlook, bonds sag
(Reuters) - U.S. stocks rose on Friday, cheered by a higher profit forecast from drug maker Merck & Co. , while bonds wobbled on fears that lurking inflation pressures could prevent an interest rate cut in the near-term.
The dollar dropped to a two-year low against the euro after Yves Mersch, a member of the European Central Bank's governing council, said that the euro zone could absorb a hard landing by the U.S. economy.
Read more at Reuters Africa
The dollar dropped to a two-year low against the euro after Yves Mersch, a member of the European Central Bank's governing council, said that the euro zone could absorb a hard landing by the U.S. economy.
Read more at Reuters Africa
IMF sees sub-Saharan Africa '07 GDP growth at 6.7 pct
(Reuters) - Economic growth in sub-Saharan Africa will accelerate this year to 6.7 percent, the highest in a decade, but more reform is essential if the gains are to stabilise and broaden, the IMF said on Friday.
The International Monetary Fund (IMF) said in its annual report on sub-Saharan Africa that while oil-exporting countries would likely see their economies expand by 10 percent or more, non-oil states will also grow by around 5 percent in 2007.
Read more at Reuters Africa
The International Monetary Fund (IMF) said in its annual report on sub-Saharan Africa that while oil-exporting countries would likely see their economies expand by 10 percent or more, non-oil states will also grow by around 5 percent in 2007.
Read more at Reuters Africa
CORRECTED - CORRECTED-Novartis eyes share buybacks, biotech buys-report
(Reuters) - When asked whether Novartis was interested in buying U.S. biotechnology firm MedImmune , Vasella said biotech firms were "on our radar screen," but declined to comment further.
"It is possible that we do both, acquisitions and share buybacks ," Vasella said in an interview in newspaper Finanz und Wirtschaft.
Read more at Reuters.com Mergers News
"It is possible that we do both, acquisitions and share buybacks ," Vasella said in an interview in newspaper Finanz und Wirtschaft.
Read more at Reuters.com Mergers News
Subscribe to:
Posts (Atom)
